Effect of Melatonin and Cisplatin on Cervical Cancer Cells: Role of TRPV1 Channels
Authors:
Open Access
- 26 October 2025
- journal article
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 78 (10)
Abstract
Cisplatin, a widely used treatment for cervical cancer, and melatonin, known for enhancing the apoptotic effects of cisplatin, both play crucial roles in our study. We investigated the combined effects of these two agents on HeLa cervical cancer cells, with focus on the role of TRPV1 channels, which we found to be of significant importance. According to the treatment performed, the cell samples were divided into seven main groups: control, cisplatin,Cisplatin + capsazepine (TRPV1 antagonist), melatonin, melatonin + capsazepine, cisplatin + melatonin, and cisplatin + melatonin + capsazepine. Each group was stimulated with capsaicin (TRPV1 agonist) in all analyses. We measured apoptosis, cytosolic calcium, intracellular reactive oxygen species, mitochondrial depolarization, caspase-9, and caspase-3 levels. The combined application of cisplatin and melatonin led to a significant increase in apoptosis levels, which were statistically significantly higher compared to both the control group and the group treated with cisplatin alone (p<0.001) (Fig. 2). This notable increase underscores the potential of this combined treatment in treating cervical cancer. Our findings strongly suggest that melatonin could be a promising adjunct therapy for cisplatin-induced cervical cancer. By elevating cytosolic Ca2+ levels, promoting apoptosis, and increasing intracellular ROS levels through TRPV1 channels, melatonin indicated potential as an effective therapeutic option (Fig. 1–4).Keywords
This publication has 16 references indexed in Scilit:
- Melatonin promotes orofacial antinociception in adult zebrafish by modulating TRP channelsPhysiology & Behavior, 2023
- Human TRPV1 structure and inhibition by the analgesic SB-366791Nature Communications, 2023
- Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug CisplatinDrug Research, 2022
- Transient receptor potential ankyrin 1 mediates cisplatin-induced apoptosis in renal tubular cells via calcium-dependent signaling pathwayAnnals of Palliative Medicine, 2021
- Melatonin and Selenium Suppress Docetaxel-Induced TRPV1 Activation, Neuropathic Pain and Oxidative Neurotoxicity in MiceBiological Trace Element Research, 2020
- Melatonin: A new inhibitor agent for cervical cancer treatmentJournal of Cellular Physiology, 2019
- Curcumin inhibits oxidative stress-induced TRPM2 channel activation, calcium ion entry and apoptosis values in SH-SY5Y neuroblastoma cells: Involvement of transfection procedureMolecular Membrane Biology, 2016
- Synergic Effects of Doxorubicin and Melatonin on Apoptosis and Mitochondrial Oxidative Stress in MCF-7 Breast Cancer Cells: Involvement of TRPV1 ChannelsThe Journal of Membrane Biology, 2015
- Transient Receptor Potential Vanilloid 1 is Essential for Cisplatin-Induced Heat Hyperalgesia in MiceMolecular Pain, 2010
- Short Interfering RNA against Transient Receptor Potential Vanilloid 1 Attenuates Cisplatin-Induced Hearing Loss in the RatThe Journal of Neuroscience, 2008